Table 3.

Adverse events during 12 weeks of follow-up after PB MNC-QQ cell transplantation.

NCI-CTCAE (version 3.0) grade	Adverse events
Grade 5 (death)	None
Grade 4 (life-threatening)	None
Grade 3 (severe)	Cellulitis at an injection sitea (N = 1) Restenosis (N = 4) Chronic subdural hematoma (N = 1)
Grade 1-2 (mild to moderate)	Clinical symptoms   Bedsore (N = 1) Heterotopic ulcer (N = 1) Urinary tract infection (N = 1) Arthralgia (N = 1) Dyspnea (N = 1) Hypoperfusion (N = 1) Labial herpes simplex (N = 1) Diarrhea (N = 1) Patellofemoral joint pain (N = 1) Fever due to respiratory infection (N = 1)
	Laboratory data abnormalities   ALP elevation (hepatic-cystic system failure) (N = 1) CRP elevation (N = 1)

Note:

Adverse event related to MNC-QQ cell transplantation.

Abbreviations: ALP, alkaline phosphatase; CRP, C-reactive protein; NCI-CTCAE, National Cancer Center Common Terminology Criteria for Adverse Events.